From the Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Center for Clinical Standards & Quality, Centers for Medicare & Medicaid Services, Washington, DC.
Cancer J. 2022;28(2):121-124. doi: 10.1097/PPO.0000000000000585.
In this commentary, we provide an overview about the surge of telemedicine services during the COVID-19 pandemic, describe the cancer care continuum and existing evidence regarding the use of telemedicine across the continuum, and offer our perspective on existing opportunities to advance the use of telemedicine in clinical care, research, and policy. While research implications are relevant to an international audience, our focus pertains specifically to health care delivery and policy in the United States.
在这篇评论中，我们概述了 COVID-19 大流行期间远程医疗服务的激增，描述了癌症护理连续体以及整个连续体中使用远程医疗的现有证据，并就现有机会提出了我们在临床护理、研究和政策中推进远程医疗使用的看法。虽然研究意义与国际受众相关，但我们的重点特别针对美国的医疗保健服务和政策。
